Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Kleinman, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Kleinman, A.
Related Collections
Right arrow Somatoform
Psychosomatic Medicine 69:829 (2007)
© 2007 American Psychosomatic Society


SOMATIC PRESENTATIONS: OVERVIEW

Somatic Presentations—A Challenge for DSM-V

Joel E. Dimsdale, MD, Vikram Patel, MB, Yu Xin, MD and Arthur Kleinman, MD

Department of Psychiatry, University of California, San Diego, San Diego, CA (Dimsdale)
London School of Hygiene and Tropical Medicine, London, UK (Patel)
Peking University, Beijing, China (Xin)
Department of Anthropology, Harvard University, Cambridge, MA (Kleinman)

This special section of Psychosomatic Medicine presents a series of brief overviews concerning one of the most challenging areas of psychiatric diagnosis. Somatic presentations are arguably present in virtually every psychiatric diagnosis, but they are particularly evident in the highly disparate diagnoses of somatization disorder, somatoform disorder, conversion disorder, pain disorder, hypochondriasis, body dysmorphic disorder, and psychological factors affecting medical conditions.

How distress is "embodied" is one of the central challenges of contemporary psychiatry. Our epidemiological knowledge base is limited, particularly in the developing world. Thus, cross-cultural insights, although fervently desired, are based on limited data. Even in Europe and the United States, contemporary epidemiological studies rarely sample somatic issues thoroughly, instead focusing, if at all, on the relatively rare occurrence of somatization disorder. Studies describing and comparing the phenomenology, natural history, and treatment response of the current categories of mental disorders with prominent somatic presentations are scarce. Similarly, there are few studies utilizing contemporary neural imaging tools and neural immune probes for understanding these complex illnesses that are so frequently associated with relatively nonspecific somatic symptoms. The conceptual "borders" between these somatic presentations and other psychiatric disorders, such as depressive disorders, are also ill defined.

This set of papers, written by international experts from different backgrounds, highlights some of the many challenges involved in diagnosing psychosomatic phenomena in the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V). In general, the papers stem from a landmark meeting in Beijing in September 2006. Two of the papers provide context for this special section. The paper by Regier (1) describes the overall process by which the American Psychiatric Association, the National Institutes of Health, and the World Health Organization are working together to craft the next DSM that will also be more convergent with International Classification of Diseases. The paper by Oken (2) summarizes how psychosomatic disorders have been dealt with in successive versions of the DSM. The rest of the papers discuss culture (3–5), epidemiology (6,7), comorbidity (8,9), biology (10), and treatment (11–13) of these puzzling disorders.

Efforts to standardize psychiatric diagnosis are relatively recent phenomena. As such, accumulating knowledge from the diverse disciplinary perspectives, which characterize modern psychiatry, and from across the world will determine our understanding of the diagnostic boundaries of somatoform presentations. We can perhaps have tolerance for the shortcomings of our efforts to achieve diagnostic clarity if we recall how long it has taken to map the world geographically. We hope that this set of papers will provide some navigational assistance to the ongoing work in developing an improved DSM.

Drs. Dimsdale, Patel, Xin, and Kleinman served as guest editors for this collection of papers.

NOTES

This article is being co-published by Psychosomatic Medicine and the American Psychiatric Association.

DOI:10.1097/PSY.0b013e31815b005d

REFERENCES

  1. Regier D. Somatic presentations of mental disorders: refining the research agenda for DSM-V. Psychosom Med 2007;69:827–8.[Free Full Text]
  2. Oken D. Evolution of psychosomatic diagnosis in DSM. Psychosom Med 2007;69:830–1.[Free Full Text]
  3. Kirmayer L, Sartorius N. Cultural models and somatic syndromes. Psychosom Med 2007;69:832–40.[Abstract/Free Full Text]
  4. Lee S, Kleinman A. Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosom Med 2007;69:846–9.[Abstract/Free Full Text]
  5. Escobar J, Gureje O. Influence of cultural and social factors on the epidemiology of idiopathic somatic complaints and syndromes. Psychosom Med 2007;69:841–5.[Abstract/Free Full Text]
  6. Kanaan R, Lepine JP, Wessely S. The Association or otherwise of the functional somatic symptoms. Psychosom Med 2007;69:855–9.[Abstract/Free Full Text]
  7. Rief W, Rojas G. Stability of somatoform symptoms—implications for classification. Psychosom Med 2007;69:864–9.[Abstract/Free Full Text]
  8. Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007;69:860–3.[Abstract/Free Full Text]
  9. Hasin D, Katz H. Somatoform and substance use disorders. Psychosom Med 2007;69:870–5.[Abstract/Free Full Text]
  10. Dimsdale J, Dantzer R. A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med 2007;69:850–4.[Abstract/Free Full Text]
  11. Mayou R. Are treatments for common mental disorder also effective for functional symptoms and disorders? Psychosom Med 2007;69:876–80.[Abstract/Free Full Text]
  12. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007;69:881–8.[Abstract/Free Full Text]
  13. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007;69:889–900.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Kleinman, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Kleinman, A.
Related Collections
Right arrow Somatoform


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS